CYP2C19 and infection: In the multivariate analysis of NM and MR/UM adjusting for age, sex, PPI dose, and comorbidities, CYP2C19 metabolizer status was a significant risk factor for infectious events with higher infection rates in normal metabolizers compared to those with rapid/ultra-rapid metabolizing capacity [20].